Live from the NIH registry
Studies recruiting near Boise right now
Top 25 of 253 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (1.6 mi)
· Sponsor: Sameek Roychowdhury
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
St. Luke's Cancer Institute: Boise — Boise, Idaho (1.6 mi)
· Sponsor: Eli Lilly and Company
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
ASR Idaho CGI — Boise, Idaho (1.6 mi)
· Sponsor: Mel Mont Medical
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8
N/A
Observational 1,000 participants sought
St. Luke's Cancer Institute — Boise, Idaho (1.6 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
St. Luke's Cancer Institute — Boise, Idaho (1.6 mi)
· Sponsor: Hoffmann-La Roche
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi)
· Sponsor: SWOG Cancer Research Network
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
St Lukes Anesthesia Associates of Boise — Boise, Idaho (1.6 mi)
· Sponsor: Yale University
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
Humphreys Diabetes Center — Boise, Idaho (1.6 mi)
· Sponsor: Pfizer
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Express Lab — Garden City, Idaho (1.5 mi)
· Sponsor: Pfizer
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: NRG Oncology
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
St. Luke's Children's Endocrinology — Boise, Idaho (1.6 mi)
· Sponsor: BioMarin Pharmaceutical
Long-Term Outcomes Following HBOT
Traumatic Brain Injury, Post-Concussive Symptoms
Phase 2
Interventional 35 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (1.6 mi)
· Sponsor: Summit Hyperbarics and Wellness
A Long-Term Follow-Up Study of Participants Exposed to REACT
Diabetic Kidney Disease, Chronic Kidney Diseases
N/A
Observational 80 participants sought
Boise Kidney & Hypertension Institute — Meridian, Idaho (8.1 mi)
· Sponsor: Prokidney
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Saint Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho (1.6 mi)
· Sponsor: Nicole Hamblett
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.1 mi)
· Sponsor: Novo Nordisk A/S
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Ada West Research — Meridian, Idaho (8.1 mi)
· Sponsor: LEO Pharma
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
St Luke's Clinic - Neurology — Meridian, Idaho (8.1 mi)
· Sponsor: Pfizer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Paradigm Clinical Research - Boise, ID — Boise, Idaho (1.6 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Meridian, Idaho (8.1 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Cystic Fibrosis
Phase 1
Interventional 20 participants sought
St. Lukes CF Center of Idaho — Boise, Idaho (1.6 mi)
· Sponsor: Krystal Biotech, Inc.